The three articles we read as a class this
week all hit upon the issues that arise when we take medicine across borders.
In some ways, this is a new phenomenon, possible only because of advances in
transportation and communication, but in many ways it is much older.
All three articles relate the modern
medical occurrences they are describing back to some older, historical example.
Scheper-Hughes's article "The Global Traffic in Human Organs"
mentions how many rumors of organ stealing, "are part of a universal class
of popular culture dating back to at least medieval
Europe,"(Scheper-Hughes 202). In a similar manner, Roberts and
Scheper-Hughes treat Bram Stoker's Count
Dracula, where the vampire leaves his rural castle for London, seeking a
fresh supply of blood, as the original medical migration. The theme of
these seemingly modern procedures having ties to a more unscientific past
continues in Song's article, "Biotech Pilgrims and the Transnational Quest
for Stem Cell Cures". Here the author relates the contemporary practice of
US citizens traveling to China for Stem Cell treatments to religious
pilgrimages throughout history. She ties one particular patient, Tim, to the
Puritans who fled English persecution to America, comparing how the Puritans
viewed the Church of England’s repression to Tim’s take on President George W.
Bush stopping stem cell research in the US.
It seemed peculiar to me that all three
pieces felt some sort of need to place these experiences of modern medicine
back to older traditions. To me, as a reader, it served as a reminder that what
is happening with all of these issues discussed in the articles (the organ
trade, “medical tourism”, transfer of medical practices like drug
rehabilitation, biotech pilgrimages) aren’t as novel as they seem. Rather they
are a part of a historical pattern of reaction and resistance to medical
advancement. Part of that advancement involves many mistakes on the part of the
government and medical field when introducing these practices. In the organ
trade, socioeconomic divisions and corruption of countries prevent what
Scheper-Hughes presents as a more ethical organ donating system from
developing. Asthma researchers in Baltimore made the mistake of thinking their
research on asthma in African-Americans could translate to the Afro-Caribbean
population of Barbados. Surely mistakes will be made in the implementation of
stem cell treatments, which brings a whole host of moral quandaries with it.
But it is also a mistake to fear the
advent of new biotechnology because of potential mistakes. This is made most
clear in Song’s article, where she mentions how fears of stem cell technology
result in government legislation preventing research in the US. The impact of
this is that the citizens who could most benefit from the application of the
research feel betrayed by their own government and are forced to travel at
great expense to China for treatment. Medical advancements are never
implemented perfectly at first, but fearing progress comes with its own price.
No comments:
Post a Comment